Cancer Detection in the Blood, Urine, and Bone Marrow
common.study.values.description
“Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow”
Patients with resectable solid primary cancers and even limited number of metastases are potentially curable. However, most patients develop recurrences despite surgery. Also, early detection of lung cancer with low dose CT screening may cure patients at an early stage. Circulating and disseminated tumor cell (CTC/DTC) and circulating cell-free (cf) DNA isolation from the blood, urine and bone marrow will increase understanding of cancer spread and advance knowledge to develop individualized therapies and improve screening.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Diagnostic Test - Test for circulating tumor cells, DNA alterations
participant.views.study.view.additional
participant.views.study.view.scientific-title
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers and Subjects Undergoing Lung Cancer Screening
common.study.values.clinical-trial-id
NCT03551951
participant.views.study.view.id
DdwMra
